Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-009604
Filing Date
2025-04-02
Accepted
2025-04-02 15:46:01
Documents
1
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 form4-04022025_070458.html 4  
1 form4-04022025_070458.xml 4 3147
  Complete submission text file 0001415889-25-009604.txt   4528
Mailing Address 5203 BRISTOL INDUSTRIAL WAY BUFORD GA 30518
Business Address
BRAWLEY OTIS W (Reporting) CIK: 0001213029 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40502 | Film No.: 25804076

Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Issuer) CIK: 0001806952 (see all company filings)

EIN.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)